ology 2020;35:369-83.
41. Alameer A, Aherne T, Naughton P, et al. Peri-procedural thromboprophylaxis in the prevention of DVT in varicose vein interventions: a
systematic review and meta-analysis. Surgeon 2022;20:e392-404.
42. Meissner MH, Khilnani NM, Labropoulos N, et al. The symptomsvarices-pathophysiology classiﬁcation of pelvic venous disorders: a
report of the American vein & lymphatic society international
working group on pelvic venous disorders. Phlebology 2021;36:
342-60.
43. Meissner MH, Khilnani NM, Labropoulos N, et al. The SymptomsVarices-Pathophysiology classiﬁcation of pelvic venous disorders: A
report of the American Vein & Lymphatic Society International
Working Group on Pelvic Venous Disorders. J Vasc Surg Venous
Lymphat Disord 2021;9(3):568-84.
44. Murad MH, Swiglo BA, Sidawy AN, Ascher E, Montori VM. Methodology for clinical practice guidelines for the management of arteriovenous access. J Vasc Surg 2008;48(5 Suppl):26S-30S.
45. Murad MH, Montori VM, Sidawy AN, et al. Guideline methodology of
the Society for Vascular Surgery including the experience with the
GRADE framework. J Vasc Surg 2011;53:1375-80.
46. Murad MH. Clinical practice guidelines: a primer on development
and dissemination. Mayo Clin Proc 2017;92:423-33.
47. Alonso-Coello P, Schünemann HJ, Moberg J, et al. GRADE Evidence
to Decision (EtD) frameworks: a systematic and transparent
approach to making well informed healthcare choices. 1: introduction. BMJ 2016;353:i2016.
48. Porter JM